Business Context and Reporting Period
Molina Healthcare, Inc. filed this Form 8-K on May 22, 2017, reporting an event that occurred on May 19, 2017. The filing concerns a material definitive agreement regarding the Company's existing credit facility.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, or liquidity ratios. The only financial metric disclosed is the aggregate principal amount of the Company's unsecured revolving credit facility, which is $500.0 million.
Material Changes
On May 19, 2017, the Company entered into a Third Amendment to its Credit Agreement dated June 12, 2015. Key modifications include:
- Specified Cash Definition: The amendment permits cash subject to customary escrow arrangements or held in segregated accounts to be netted from the consolidated net leverage ratio, provided the cash is used to repay other indebtedness or fund a permitted acquisition.
- Negative Pledge Covenant: A carve-out was added to allow for the aforementioned escrow arrangements and segregated accounts, even if they are deemed to have incurred an encumbrance.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. It does not disclose specific risks or contingencies beyond the standard legal qualification that the summary is subject to the full text of the Third Amendment.
Investor Verification Checklist
- Review the full text of the Third Amendment to the Credit Agreement (Exhibit 10.1) to understand the specific limitations on the use of escrowed or segregated cash.
- Verify the impact of the leverage ratio modification on the Company's current debt covenants.
- Confirm the status of any pending permitted acquisitions or debt repayments that may utilize the newly defined "Specified Cash."